CellaVision AB (publ)
STO: CEVI.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Simon Ostergaard
- Employees
- 228
- Headquarters
- Lund, Sweden
- IPO year
- 2007
- Market cap
- SEK 2.8B
- Website
- https://www.cellavision.com
Loading CEVI…
Loading profile data…Frequently asked questions about CEVI
What does CellaVision AB (publ) (CEVI.ST) do?
CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body...
Where does CEVI.ST trade?
CellaVision AB (publ) (CEVI.ST) trades on the Stockholm Stock Exchange.
What sector is CEVI.ST in?
CellaVision AB (publ) (CEVI.ST) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of CellaVision AB (publ)?
Simon Ostergaard is the chief executive officer of CellaVision AB (publ) (CEVI.ST).
Where is CellaVision AB (publ) headquartered?
CellaVision AB (publ) is headquartered in Sweden.
Does CEVI.ST pay a dividend?
Yes — CellaVision AB (publ) (CEVI.ST) paid a trailing twelve-month dividend of SEK 5.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did CEVI.ST go public?
CellaVision AB (publ) (CEVI.ST) completed its initial public offering in 2007.